Jill E Blind
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 25, 2026
Biosafety Guidelines for Viral Vector-Based Gene Therapies: A Resource for Healthcare and Pharmacy Professionals.Sumit Ghosh, Jill Blind, Allison Fowler
|Feb 02, 2026
From innovation to implementation: Health-system pharmacy integration of cell and gene therapies.Danielle Pennock, Kelin Wheaton, Blake Shay
|Feb 28, 2024
A comprehensive literature scoping review of infection prevention and control methods for viral-mediated gene therapies.Jill E Blind, Sumit Ghosh, Taylor D Niese
|Apr 03, 2023
A call to action: Health-system pharmacists must stand up to meet the growing demand for cellular-based therapies.Jill E Blind, Diana N Nowicki, Kimberly McConnell
|Jan 17, 2023
Clinical change 2 years from start of elexacaftor-tezacaftor-ivacaftor in severe cystic fibrosis.Karen S McCoy, Jill Blind, Terri Johnson
|Oct 06, 2022
Implementation and Patient Outcomes of a Pediatric COVID-19 Monoclonal Antibody Program.Jill E Blind, Matt Sapko, Alex Killough
Pageof 1
